These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2447630)

  • 1. Diagnostic value of serum interferon level in systemic lupus erythematosus.
    Ghyka G; Matei I; Savi I
    Med Interne; 1987; 25(4):239-43. PubMed ID: 2447630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors.
    Zippel D; Lackovic V; Kocisková D; Rovenský J; Borecký L; Stelzner A
    Acta Virol; 1989 Sep; 33(5):447-53. PubMed ID: 2483602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating interferon in human autoimmune diseases.
    Hooks JJ; Moutsopoulos HM; Notkins AL
    Tex Rep Biol Med; 1981-1982; 41():164-8. PubMed ID: 6184802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of serum interferon with some clinical and humoral signs of systemic lupus erythematosus.
    Matei I; Ghyka G; Savi I; Tudor A
    Med Interne; 1990; 28(4):289-94. PubMed ID: 1713346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.
    Cederblad B; Blomberg S; Vallin H; Perers A; Alm GV; Rönnblom L
    J Autoimmun; 1998 Oct; 11(5):465-70. PubMed ID: 9802930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological characterization of systemic lupus erythematosus in patients with circulating interferon and migration inhibitory factor.
    Rovenský J; Bosák V; Zitnan D; Lackovic V; Borecký L; Pekárek J; Svejcar J; Lukác J; Matoková M
    Int J Clin Pharmacol Res; 1984; 4(6):465-8. PubMed ID: 6085328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon and natural killer cells in systemic lupus erythematosus.
    Strannegård O; Hermodsson S; Westberg G
    Clin Exp Immunol; 1982 Nov; 50(2):246-52. PubMed ID: 6185256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interleukin 10 in disseminated lupus erythematosus].
    Emilie D
    J Soc Biol; 2002; 196(1):19-21. PubMed ID: 12134628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus.
    Batteux F; Palmer P; Daëron M; Weill B; Lebon P
    Eur Cytokine Netw; 1999 Dec; 10(4):509-14. PubMed ID: 10586117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells and interferon responses in patients with systemic lupus erythematosus.
    Tsokos GC; Rook AH; Djeu JY; Balow JE
    Clin Exp Immunol; 1982 Nov; 50(2):239-45. PubMed ID: 6817954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
    Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project".
    Cervera R; Abarca-Costalago M; Abramovicz D; Allegri F; Annunziata P; Aydintug AO; Bacarelli MR; Bellisai F; Bernardino I; Biernat-Kaluza E; Blockmans D; Boki K; Bracci L; Campanella V; Camps MT; Carcassi C; Cattaneo R; Cauli A; Cervera R; Chwalinska-Sadowska H; Contu L; Cosyns JP; Danieli MG; DCruz D; Depresseux G; Direskeneli H; Domènech I; Espinosa G; Fernández-Nebro A; Ferrara GB; Font J; Frutos MA; Galeazzi M; Garcìa-Carrasco M; García Iglesias MF; García-Tobaruela A; George J; Gil A; González-Santos P; Grana M; Gül A; Haga HJ; de Haro-Liger M; Houssiau F; Hughes GR; Ingelmo M; Jedryka-Góral A; Khamashta MA; Lavilla P; Levi Y; López-Dulpa M; López-Soto A; Maldykowa H; Marcolongo R; Mathieu A; Morozzi G; Nicolopoulou N; Papasteriades C; Passiu G; Perelló I; Petera P; Petrovic R; Piette JC; Pintado V; de Pita O; Popovic R; Pucci G; Puddu P; de Ramón E; Ramos-Casals M; Rodríguez-Andreu J; Ruiz-Irastorza G; Sanchez-Lora J; Sanna G; Scorza R; Sebastiani GD; Sherer Y; Shoenfeld Y; Simpatico A; Sinico RA; Smolen J; Tincani A; Tokgöz G; Urbano-Márquez A; Vasconcelos C; Vázquez JJ; Veronesi J; Vianna J; Vivancos J;
    Autoimmun Rev; 2006 Mar; 5(3):180-6. PubMed ID: 16483917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.
    Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-I interferons and systemic lupus erythematosus.
    Koutouzov S; Mathian A; Dalloul A
    Autoimmun Rev; 2006 Oct; 5(8):554-62. PubMed ID: 17027892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon inhibitor in the blood of patients with systemic lupus erythematosus.
    Chadha KC; Ambrus JL; Stadler I; Ambrus JL
    J Biol Regul Homeost Agents; 1991; 5(1):1-9. PubMed ID: 1715634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
    Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus.
    Yang D; Wang H; Ni B; He Y; Li J; Tang Y; Fu X; Wang Q; Xu G; Li K; Yang Z; Wu Y
    Mol Immunol; 2009 Apr; 46(7):1432-42. PubMed ID: 19200602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.